| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |